EXAM 2026/2027 PRACTICE QUESTIONS AND STUDY
GUIDE COMPLETE ACCCURATE EXAM REAL QUESTIONS
WITH WELL ELABORATED SOLUTIONS AND DETAILED
RATIONALES (100% CORRECT VERIFIED ANSWERS)
LATEST UPDATE 2026 EDIDTION || GUARANTEED
PASS
You examine Jane, a 24-year-old woman who has an acute asthma
flare following a 3-day history of upper respiratory tract symptoms
(clear nasal discharge, dry cough, no fever). She has a history of
moderate persistent asthma that is in good control and an
acceptable peak expiratory flow (PEF). She is using budesonide
(Pulmicort) and albuterol as directed and continues to have
difficulty with coughing and wheezing. At home her PEF is 55% of
personal best.
In the office, her forced expiratory volume at 1 second (FEV1) is
65% of predicted.
Her medication regimen should be adjusted to include:
Oral Prednisone burst
The cornerstone of moderate persistent asthma controller drug
therapy is the use of:
Inhaled Corticosteroids
,You see a 34-year-old man with moderate persistent asthma who
has an asthma flare, and a regimen of oral prednisone is
prescribed for 7 days. Which of the following is true?
A taper is not needed if the prednisone regimine is usually for 7
days or less
According to GOLD COPD guidelines, which of the following
medications is indicated in all COPD stages?
Short-acting inahled beta-2-agonist
Which of the following states has mandated third-party
reimbursement parity for NP services?
A) California
B) Texas
C) Oregon
D) Florida
Oregon
In how many states do NPs have independent scope of practice and prescriptive
authority without physician collaboration?
A) 11
B) 24/27
C) 35
D) 50
24/27
,Select the correct instructions for delivering medication through
an MDI (metered dose inhaler).
Shake, Exhale, Open Mouth, Start inhaling, Actuate device, Deep
Inhalation, Hold breath 5 sec, Exhale, Wait 1-5 min, Repeat
A patient with chronic obstructive pulmonary disease (COPD) has
a history of three moderate exacerbations and one hospitalization
over the past 6 months.
LABA and long-acting muscarinic antagonist (LAMA)
This patient can be categorized as group E due to their history of
exacerbations and recent hospitalization. For group E patients,
LABA and LAMA together is the preferred choice for initial therapy
rather than using either agent alone. The use of LABA and ICS in
COPD patients is not recommended. Group A patients should be
offered a bronchodilator treatment.
, A patient presents with concern for an asthma exacerbation. The
patient is tachypneic, heart rate is 125 beats/min, and the patient is
using accessory muscles to assist breathing. Which of the
following diagnostic tools should be used to assess the severity of
the asthma attack?
Peak flow meter (or spirometer)
The best method to objectively assess the severity of an asthma
attack is measurement of maximal expiratory airflow with a peak
flow meter (or spirometer). Pulse oxygen saturation testing
provides a noninvasive screening test for hypoxemia. Arterial
blood gas to assess for hypercapnia is not necessary in most
patients. It may be more appropriate in patients who are more
critically ill with worsening respiratory status or show signs of
hypercapnia (e.g., depressed consciousness). A chest x-ray is not
routinely recommended during acute asthma attacks because the
findings are often nonspecifi